Sciences Innovation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

This is real money. You are the most important part of the show, so join our live conversation for the next half hour on twitter and on facebook. Com. What is wrong with gm . Is this a company you can trust anymore . Should you buy a gm vehicle . Are you safe in the one you have . These questions all became more relevant hours ago. As they announced another recall. Another 1. 5 until cars. The latest in a tidal wave of mistakes. And for General Motors a company desperately trying to reinvent itself with a new ceo, the timing and resulting justifying loss of confidence against American Consumer...

This is real money. You are the most important part of the show, so join our live conversation for the next half hour on twitter and on facebook. Com. What is wrong with gm . Is this a company you can trust anymore . Should you buy a gm vehicle . Are you safe in the one you have . These questions all became more relevant hours ago. As they announced another recall. Another 1. 5 until cars. The latest in a tidal wave of mistakes. And for General Motors a company desperately trying to reinvent itself with a new ceo, the timing and resulting justifying loss of confidence against American Consumer...

The Spring 2024 Series on Reproductive Justice, part of the 2023-2024 Rethinking Gender Series at The University of Akron, comes to campus this week, with events on Wednesday, Feb. 28, and Feb. 29. Presented by The University of Akron Women’s Studies Program, Department of Sociology, and EX[L] Center, along with Elizabeth’s Bookshop and Writing Center,...

Genomics company Broken String Biosciences has appointed Gavin Burns, PhD, as Vice President of Quality and Operations with responsibility for building and optimising Broken String’s teams, processes and systems required to develop and scale its Next Generation Sequencing (NGS)-based DNA break-mapping platform technology in support of gene-editing applications. Click to read more...

Bicara, founded in 2020 and based in Cambridge, Massachusetts, is a clinical-stage biotechnology company currently developing dual-action biologics to produce a potent and durable immune response.